# OnCo record leucid-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/leucid-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "leucid-bio" ;
  schema:name "Leucid Bio"@en ;
  schema:description "Leucid Bio is a London company, spun out of King's College London, that re-engineers CAR-T cells, a patient's own immune cells modified to find cancer, so that they work against solid tumours. Its first product, LEU011, is in an early trial."@en ;
  schema:url <https://onco.cc/companies/leucid-bio/>, <https://www.leucid.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.leucid.com/>, <https://www.leucid.com/about>, <https://clinicaltrials.gov/study/NCT06193902> ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:trials <https://onco.cc/trials/nct06193902/> .